Further imaging in the program confirmed reductions in both visceral and subcutaneous belly fat
Peripheral IR primarily involves reduced insulin-mediated glucose uptake by skeletal muscle and adipose tissue, driven by defects in the insulin receptor substrate and downstream signaling pathways such as phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt), leading to diminished translocation of glucose transporter type 4 (SLC2A4/GLUT4) and glucose uptake [5]
In addition to reduction in A1C and body weight, the semaglutide 2.0 mg arm of the trial saw a greater proportion of patients achieve an A1C less than 7% (67.6% vs 57.5% [OR, 1.60
Objective data helps determine whether therapy is working and how adjustments should occur
While semaglutide is effective for most people, it doesnt work for everyone
Current diagnosis: obesity, type 2 diabetes, or both